VIATRIS (acquired by Meda AB)
17 articles with VIATRIS (acquired by Meda AB)
Viatris Inc. announced the company will take part in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021.
Viatris Inc. Reports Strong First Quarter 2021 Financial Results, Reaffirms 2021 Guidance and Announces Inaugural Quarterly Dividend
Viatris Inc. reported results for the first quarter of 2021, which demonstrate the strength of its differentiated operating platform and commercial capabilities, its broad and diverse product portfolio and its strong R&D platform.
Viatris Inc. Releases Inaugural Sustainability Report, Reinforcing its Commitment to Better Health and Better Communities Worldwide
New company highlights patients, holistic approach to providing access to medicine, and path to further progress
Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021.
Viatris Inc. announced the company will take part in a virtual fireside chat at the BofA Securities 2021 Health Care Conference on Tuesday, May 11, 2021.
Viatris Inc. (NASDAQ: VTRS) plans to release its first quarter 2021 financial results on Monday, May 10 , before the open of the U.S. financial markets. The company also will host a webcast at 10 a.m. ET on May 10 to discuss the results.
Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Abbreviated New Drug Application Generic Version of Symbicort® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that the U.S. Food and Drug Administration (FDA) granted tentative approval of budesonide
The biopharma industry remained strong, as demand for COVID-related products skyrocketed. However, some companies are facing layoffs. Here's a brief overview.
Viatris Inc. Hosts Inaugural Investor Day Outlining Unique and Differentiated Business Model, High-Quality Operational Platform, and Focus on CSR and Financial Commitments
At a virtual meeting with the investment community, Viatris Inc. will outline how the company expects to lead as a new kind of healthcare company with a unique and differentiated business model, high-quality operational platform and clear focus on ensuring its sustainability priorities and financial commitments are met.
Viatris Inc. (NASDAQ: VTRS) today announced its 2021 financial guidance and reaffirmed its commitment to rapid de-leveraging, to enhancing and growing free cash flows, particularly following the phasing out of one-time and other stand up costs, to initiating a dividend, and to delivering total shareholder return (TSR).
Viatris to host its inaugural virtual Investor Day on March 1, 2021, as previously announced
Viatris Inc. (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas entered summary judgment in Mylan's favor in the lawsuit brought against it by Sanofi related to its EpiPen® products. Viatris is extremely pleased with this significant action by the Court as it rejects Sanofi's baseless attempts
Viatris Inc. Recommends Caution on TRC Capital Corp.'s Attempt to Acquire Shares at a Significant Discount via Mini-Tender Offer
Viatris Inc. has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation to purchase up to 6,000,000 shares, or approximately 0.497 percent, of the outstanding common stock of Viatris at a price of $16.50 per share in cash.
Viatris Inc. (NASDAQ: VTRS) today announced additional details of its previously disclosed multi-year global restructuring initiative.
Viatris Inc. Launches as a New Kind of Healthcare Company, Positioned to Meet the World's Evolving Healthcare Needs
Combination of Mylan and Pfizer's Upjohn Business Focused on Access and Improved Patient Health
Announcement follows Mylan shareholder approval of Mylan's combination with Pfizer's Upjohn
2/28/2020Biopharma and life sciences strengthen their executive leadership teams and boards with this week's Movers & Shakers.